Human T-cell lymphotropic viruses 1 and 2 (HTLV-1/2) are relatively common in Brazil but
remain silent and neglected infections. HTLV-1 is associated with a range of diseases with …

Cannabis continues to be the most used drug in the world today. Research shows that
cannabis use is associated with a wide range of adverse health consequences that may …

Background HTLV-1 infection is a neglected disease, despite estimates of 10 million people
infected worldwide and producing life-threatening illnesses in 10% of carriers. Sexual …

The description of the first human retrovirus, human T-lymphotropic virus 1 (HTLV-1), was
soon associated with an aggressive lymphoma and a chronic inflammatory …

In 2012, the number of people infected with human T cell lymphotropic virus type 1 (HTLV-1)
was estimated to be 10 million worldwide. Prevalence varies according to geographic …

Sexually transmitted infections (STIs) represent a worldwide public health problem and,
although many of them are curable, they continue to be neglected, especially in areas with a …

Objectives Human T-lymphotropic virus (HTLV) antenatal screening is not mandatory in
Spain. Surveys conducted decades ago reported HTLV-1 seroprevalence rates of 0.2 …

This study aimed to describe the prevalence of HTLV-1/2 in quilombola communities in the
state of Pará and investigate the possible sociodemographic risk factors associated with the …

Introduction Human T-lymphotropic virus (HTLV) infection is endemic in indigenous
populations of the Americas. We describe herein the prevalence of HTLV-1 and HTLV-2 …

Human T-cell lymphotropic virus type 1 (HTLV-1) infects 5–10 million people worldwide and
is the causative agent of adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated …